AA
NVS icon

ABC Arbitrage’s Novartis NVS Stock Holding History

ABC Arbitrage’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-176,749
Closed -$24.4M – 455
2025
Q4 		$24.4M Buy
+176,749
New +$23.1M 2.28% 15
2025
Q3 		– Sell
-208,708
Closed -$25.3M – 272
2025
Q2 		$25.3M Buy
+208,708
New +$23.5M 2.88% 7
2025
Q1 		– Sell
-203,424
Closed -$19.8M – 254
2024
Q4 		$19.8M Buy
+203,424
New +$21.7M 2.84% 10

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ABC Arbitrage's NVS Position: Q1 2026 in Review

ABC Arbitrage sold out of Novartis (NVS) in Q1 2026, closing a stake of 176,749 shares — an estimated $24.4M sold.

ABC Arbitrage first reported a position in NVS in Q4 2024 and held it in 3 quarters. The position peaked at $25.3M in Q2 2025. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • ABC Arbitrage reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
  • ABC Arbitrage sold 176,749 Novartis shares in Q1 2026, an estimated $24.4M.
  • ABC Arbitrage first reported a position in Novartis in Q4 2024 and held it in 3 quarters.
  • ABC Arbitrage's Novartis position peaked at $25.3M in Q2 2025.
  • 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on ABC Arbitrage's 13F filing for Q1 2026, filed 4 May 2026.